MMJ Recs

NOVEMBER 17, 2023

Promoting Research and Innovation The medical marijuana industry promotes research and innovation in the field of cannabis-based therapies. MMJ is known for its efficacy in treating various medical issues, including chronic pain, epilepsy, multiple sclerosis, and more. It oversees licensing, quality control, and patient access.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

NORML

JULY 2, 2019

Specifically, it expands the pool of patients eligible for cannabis therapy to include those with chronic pain, menstrual cramps, and epilepsy. The law also permits specific health care facility employees to operate as patient caregivers.

Law 155

Law Chronic Pain Programs Epilepsy 155

MassRoots

AUGUST 3, 2020

Only two facilities are allowed to cultivate medical cannabis for the entire state, and only nine pharmacies are licensed to distribute it to patients. Previously, the number of physicians that were allowed to recommend medical marijuana therapy was limited and so were the conditions that would qualify a person for the program.

Programs 124

Programs Banking Marijuana Conditions 124

Veriheal

MAY 17, 2021

Please don’t further the lie by voting for any form of legalization beyond the pharmaceutical remedies already available under state law.” ” State Doctors Oppose Legalization in Alabama. This is what he stated to attendees at the annual session of the Medical Association of the State Of Alabama on April 16th.

Legalization 86

Legalization Pharmaceutical Therapy Chronic Pain 86

Otherside Farms

JANUARY 3, 2023

Each US state specifies its own list of health conditions that qualify for medical marijuana. Hempland has a detailed breakdown of the states with medical marijuana programs. Here are some of the conditions that can be medicated using cannabis products: Epilepsy and seizures. The next step is where your state laws come in.

Conditions 52

Conditions Chronic Pain Marijuana Patients 52

Veriheal

JULY 6, 2021

In 2016, the law was once again reformed to allow up to 0.9% THC in CBD oils possessed by individuals that could show proof that they or an immediate family member had been diagnosed with intractable seizures or epilepsy and had obtained “a legal order or recommendation from the issuing state.” Sickle cell disease.

Programs 52

Programs Oil Epilepsy THC 52

NORML

MAY 24, 2019

This measure prohibits employers from arbitrarily discriminating against prospective employees who legally consume cannabis off-the-job in accordance with state law. The measure would permit physicians to recommend cannabis therapy to those diagnosed with anxiety, autism, opioid addiction or dependence, anorexia nervosa, among others.

Legislation 166

Legislation Hemp Access Patients 166